• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.

作者信息

Henson Jacqueline B, Corey Kathleen E

机构信息

Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

出版信息

Aliment Pharmacol Ther. 2020 May;51(10):988-989. doi: 10.1111/apt.15696.

DOI:10.1111/apt.15696
PMID:32338780
Abstract
摘要

相似文献

1
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.社论：重新审视非酒精性脂肪性肝病合并晚期纤维化时的心血管危险因素？作者回复。
Aliment Pharmacol Ther. 2020 May;51(10):988-989. doi: 10.1111/apt.15696.
2
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis?社论：重新审视非酒精性脂肪性肝病合并晚期纤维化时的心血管危险因素？
Aliment Pharmacol Ther. 2020 May;51(10):987-988. doi: 10.1111/apt.15682.
3
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.编者按：非酒精性脂肪性肝病患者F3和F4的逐步风险分层——作者回复
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040.
4
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' reply.社论：磁共振弹性成像检测的肝脏硬度与非酒精性脂肪性肝病中的心血管风险——仅仅是相关还是更为复杂？作者回复
Aliment Pharmacol Ther. 2021 Jun;53(11):1230-1231. doi: 10.1111/apt.16364.
5
Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.酒精性和非酒精性脂肪性肝炎均与心血管风险和肝纤维化相关。
Alcohol. 2018 Jun;69:63-67. doi: 10.1016/j.alcohol.2017.11.004. Epub 2017 Nov 15.
6
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
7
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现：最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
8
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.伴有肝硬化的非酒精性脂肪性肝病会增加家族性晚期纤维化风险。
J Clin Invest. 2017 Jun 30;127(7):2697-2704. doi: 10.1172/JCI93465. Epub 2017 Jun 19.
9
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.纤维化严重程度是晚期非酒精性脂肪性肝病患者死因特异性死亡率的决定因素：一项多国队列研究。
Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.
10
Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?".回复：“非酒精性脂肪性肝病中肝纤维化的评估：评估残余心血管风险的新要素？”
Dig Liver Dis. 2021 Mar;53(3):385-386. doi: 10.1016/j.dld.2021.01.014. Epub 2021 Jan 25.